原著

1)         江口太助，櫨木大祐，上野健太郎．右冠動脈左バルサルバ洞起始症の2例．心臓　2018; 50(7):777-781

2)         武井修治．JIAのぶどう膜炎に対するIL-6阻害療法の有用性．リウマチ科　2018; 59(6):630-636.

3)         武井修治．特集：私の処方2018. 全身性エリテマトーデス． 小児科臨床2018; 71(5): 993-1001.

4)         長倉智和, 今中啓之，武井修治．Blau症候群に対するTNF阻害薬の長期有効性．リウマチ科　2018; 59(2): 185-193.

5)        中川俊輔, 岡本康裕, 児玉祐一, 西川拓朗, 田邊貴幸, 河野嘉文．高リスク髄芽腫の再発後にtemozolomide単剤で長期生存している小児例 小児血液・がん学会雑誌 2018; 55(1);33-36

6)         長友理沙，野村裕一，松永愛香，中﨑奈穂，新小田雄一，楠生亮，鮫島幸二．右下肢深部静脈血栓症を発症した抗リン脂質抗体症候群の11歳男児例．小児科臨床2018. 71(10): 1757-1761.

7)         三上裕太，野村裕一，池田博美，新小田雄一，楠生亮，四俣一幸，後藤倫子，野口啓幸，鮫島幸二．異物誤飲により十二指腸閉塞を来したAngelman症候群の10歳女児例．小児科臨床2018. 71(6): 1052-1056

総説

1)         岡本康裕．ダウン症候群に合併した急性リンパ性白血病. 小児血液がん学会雑誌　　 55 (3): 217-222, 2018

著書

1)         武井修治．関節リウマチ(RA)や炎症性腸疾患(IBD)罹患女性患者の妊娠，出産を考えた治療指針の作成研究班．全身性エリテマトーデス(SLE), 関節リウマチ(RA),若年性特発性関節炎(JIA)や炎症性腸疾患(IBD)罹患女性患者の妊娠, 出産を考えた治療指針.(代表；斉藤滋) 2018.3

2)         武井修治．リウマチ性疾患．ナースとコメディカルのための小児科学p165-171, 日本小児医事出版 東京,2018

3)         上野健太郎．胸部Ｘ線検査・心電図．川崎病学（日本川崎病学会編集）診断と治療社p79-82 東京, 2018.

4)         岡本康裕. 急性リンパ性白血病, 井田博幸, 小児の治療指針, 診断と治療社, p471-474 東京, ,2018 分担執筆

5)         野村裕一．Fridericia補正式．学校心臓検診実践マニュアルQ&A．特定非営利活動法人 日本小児循環器学会編．診断と治療社.151-152. 2018.

6)         野村裕一．本態性高血圧．小児・成育循環器学．特定非営利活動法人 日本小児循環器学会編．診断と治療社.627-628. 2018

7)         野村裕一．不全型の特徴．川崎病学．日本川崎病学会編．診断と治療社.95-97. 2018

8)   益田君教、野村裕一．参考条項．川崎病学．日本川崎病学会編．診断と治療社.65-67. 2018

原著

1)        井上一利, 西川拓朗, 平木 翼, 佐々木裕美, 義岡孝子, 中川俊輔, 児玉祐一, 岡本康裕, 谷本 昭英, 河野嘉文．診断に難渋した前腕原発spindle cell sarcomaの1例．日本小児血液がん学会雑誌　2019；56（2）：212-215

2)         田中裕治．鹿児島市学校心臓検診40年の歴史を振り返って～世界に類を見ない素晴らしい検診～．　鹿児島市医報 2019; 58 （9）: 24-30

3)         池田尚弘，野村裕一，渡邉健二，島　貴史，立元千帆，益田君教，鮫島幸二．新生児-乳児消化管アレルギーによる重症脂肪肝を合併した1例．小児科臨床　2019; 72(1): 81-84

4)         谷山明彦，野村裕一，益田大幸，平林雅子，渡邉健二，新小田雄一，益田君教，山田正彦，鮫島幸二．弛張熱を呈した慢性硬膜下血腫の1歳男児例．小児科臨床　2019; 72:1431-1436.

5)         野村裕一，屋代真弓，益田君教，中村好一．不全型川崎病の増加には積極的診断が関与する．日児誌 2019;123:1634-1639

6)         長濱　潤，丸山慎介，三上裕太，楠生　亮，吉村道由，鮫島希代子，河野嘉文．ヒトパルボウイルスB19感染後に発症したGuillain-Barre syndromeの1例．小児科　2019;60(13):1825-1830

総説

1)         中江広治．心雑音を認める心疾患．赤ちゃんを守る医療者の専門誌withNEO　32（5）：75-85, 2019

2)         武井修治．小児全身性エリテマトーデス．日本臨床 77(3): 428-435,2019

3)         武井修治．小児全身性エリテマトーデス（SLE)　成人SLEと何が違うのか？．分子リウマチ治療　12(3)：121-125,2019

原著

1)         池田正樹，西川拓朗，棈松貴成，川村順平，横山智美，平井克樹，宮原恵弥子，茂見茜里，猪川和朗，岡本康裕，右田昌宏，河野嘉文．自家末梢血幹細胞移植後に肺動脈性肺高血圧と移植関連血栓性微小血管症を発症した神経芽腫患児．日本造血細胞移植学会雑誌 2020; 9(2):60

2)         竹元將人，丸山慎介，宮園明典，塩川直宏，中川俊輔，岡本康裕，井手迫俊彦，河野嘉文．後部尿道弁でピポキシル基含有抗菌薬の排泄が遅延しC5上昇が持続した1例．日本マススクリーニング学会誌 2020;30(1):43-49

3)         橋口　祥，福重寿郎，水流尚志，井上博貴，楠田政輝，西順一郎，河野嘉文．伊佐市のロタウイルスワクチン公費全額助成とロタウイルス胃腸炎入院率の減少．小児保健研究 2020;79(2):178-183.

4)         森尚子, 加藤陽子, 新小田雄一, 大曽根眞也, 嘉数真理子, 佐野弘純, 篠田邦大, 矢野道広, 石田裕二, 斎藤雄弥, 澤田明久, 豊田秀実, 足立壯一, 福島啓太郎．小児がん治療施設から見た緩和ケアの課題 ―JPLSG施設調査より　第1報―．日本小児血液・がん学会雑誌　2020;57(1):33-37

5)         加藤陽子,森尚子,新小田雄一, 大曽根眞也, 嘉数真理子, 佐野弘純, 篠田邦大, 矢野道広, 石田裕二, 斎藤雄弥, 澤田明久, 豊田秀実, 足立壯一, 福島啓太郎．小児がん患者に対する疼痛管理の現状と課題 ―JPLSG施設調査より　第2報―．日本小児血液・がん学会雑誌　　2020;57(2):178-184

6)         吉川英樹，竹元將人，江口太助．アセトアミノフェンによる急性汎発性膿疱性発疹症. 皮膚病診療　2020;42(７): 584-587

7)         稲葉泰洋，濱田　陸，原田涼子，橋本淳也，久保田亘，寺野千香子，三上直朗，幡谷浩史，黒田淳平，水口卯生子，柿沼亮太，近藤昌敏，河野達夫，本田雅敬．膵臓超音波検査を契機に診断に至ったHNF1B異常症の1例．日本小児腎臓病学会雑誌　2020

8)         川村順平，櫨木大祐，上野健太郎．遠位部胸部大動脈に限局したMid-aortic syndromeの1例．日本超音波学会雑誌　2020;47(1):29-30

9）　　山田佳奈、野村裕一、馬場淳徳、池田尚弘、久保田知洋、櫨木大祐、新小田雄一、楠生亮、鮫島　幸二．急性汎発性発疹性膿疱症を合併した難治性川崎病．小児科学会雑誌　2020. 124(12):1727-1732 

総説

1)         井之上寿美，小沢　浩．特集 小児のリハビリテーション 特集にあたって オーバービュー（低出生体重児の発達予後含む）．Clinical Rehabilitation(クリニカルリハビリテーション)　2020;29(6):522-527

2)         武井修治．小児診療ガイドラインのダイジェスト解説＆プログレスー全身性エリテマトーデス　小児科　2020;61(5):616-621.

3)         武井修治．免疫・炎症性疾患のすべてー若年性特発性関節炎(JIA)．日本医師会雑誌　2020;149(2):209-211.

4)         武井修治．小児リウマチ性疾患の呼吸器病変．小児呼吸器学会雑誌2020;31(2); in press

5)         岡本康裕．発熱性好中球減少症時の抗微生物薬　小児内科　2020;52:1499,1504,

著書

1）     久保田知洋，小児期および成人移行期小児リウマチ患者の全国調査データの解析と両者の異同性に基づいた全国的「シームレス」診療ネットワーク構築による標準的治療の均てん化研究班，若年性特発性関節炎分担班．若年性特発性関節炎における生物学的製剤使用の手引き　2020年版．羊土社．2020：50-56

2）     久保田知洋，小児期および成人移行期小児リウマチ患者の全国調査データの解析と両者の異同性に基づいた全国的「シームレス」診療ネットワーク構築による標準的治療の均てん化研究班，若年性特発性関節炎分担班．成人診療科医のための小児リウマチ性疾患移行支援ガイド．羊土社．2020：64-72

3）     久保田知洋．小児リウマチ学．日本小児リウマチ学会編．朝倉書店．2020：114-119

4）　山﨑雄一．小児リウマチ学．Blau症候群. 日本小児リウマチ学会編．朝倉書店．2020：228-231

5）     野村裕一．特殊な病型における診断上の注意点．川崎病 診断の手引きガイドブック 2020．日本川崎病学会編．診断と治療社．2020：11-12

6）     佐野のぞみ．体温調節障害．改訂版 重症心身障害 医療における治療指針－診断と治療一．2020

7）     武井修治．急性リウマチ熱．今日の臨床サポート改訂第4版，監修：今井　靖．エルゼビア・ジャパン　東京　2020(電子版)

8）     武井修治．小児リウマチ性疾患の治療と管理―その成り立ちと現状，残された問題点．小児リウマチ学　日本小児リウマチ学会編　朝倉書店　東京　2020：41-47.

9）     武井修治．若年性特発性関節炎．新機能抗体開発ハンドブック，監修：浜窪隆雄　NTS,東京2020, (電子版）

10）     武井修治．急性リウマチ熱．新臨床内科学 第10版．監修：矢崎義雄，医学書院　東京　2020;1765-1767

11）  武井修治．小児非感染性ぶどう膜炎診療の手引き2020年版　羊土社　東京　2020,(in press)

12）  武井修治．小児リウマチ性疾患．内科学12版，編：矢崎義雄　朝倉書店　東京　2020，(in press)

原著

1)        Imagawa T, Yokota S, Mori M, Miyamae T, Takei S, Imanaka H, Nerome Y, Iwata N, Murata T, Miyoshi M, Nishimoto N, Kishimoto T: Safety and efficacy of tocilizumab, an IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis. Mod Rheumatol. 2011;Jun 12 [Epub ahead of print]

2)        Kawamura H, Nishi J, Imuta N, Tokuda K, Miyanohara H, Hashiguchi T, Zenmyo M, Yamamoto T, Ijiri K, Kawano Y, Komiya S. Quantitative analysis of biofilm formation of methicillin-resistant Staphylococcus aureus (MRSA) strains from patients with orthopaedic device-related infections. FEMS Immunol Med Microbiol. 2011;63(1):10-15

3)        Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Takei S, Tanaka Y, Ito K, Yamanaka H.Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients. Ann Rheum Dis 2011;70(12): 2148-2151

4)        Koike T, Harigai M, Naoki Ishiguro N, Inokuma S, Takei S, Takeuchi T, Yamanaka H, Tanaka Y. Safety and effectiveness of adalimumab in Japanese patients with rheumatoid arthritis: a report of the first 3,000 patients treated during postmarketing surveillance. Mod Rheumatol. 2011; Oct 13. [Epub ahead of print].

5)        Lee S, Sanefuji M, Watanabe K, Uematsu A, Torisu H, Baba H, Kira R, Takada Y, Ishizaki Y, Toyoshima M, Aragaki F, Hata D, Hara T. Clinical and MRI characteristics of acute encephalopathy in congenital adrenal hyperplasia. J Neurol Sci. 2011;306(1-2):91-3

6)        Matsumoto K, Shigemi A, Yaji K, Shimodozono Y, Takeda Y, Ikawa K, Morikawa N, Miyanohara H, Kawamura J, Orita M, Tokuda K, Nishi J, Yamada K: Reduction in the incidence of MRSA with use of alcohol-based hand rub solutions and gloves. J Infect Chemother 2011 Sep 6 [Epub ahead of print]

7)        Miyahara E, Nishie M, Takumi S, Miyanohara H, Nishi J, Yoshiie K, Oda H, Takeuchi M, Komatsu M, Aoyama K, Horiuchi M, Takeuchi T. Environmental mutagens may be implicated in the emergence of drug-resistant microorganisms. FEMS Microbiol Lett. 2011;317(2):109-116

8)        Mori M, Takei S, Imagawa T, Imanaka H, Nerome Y, Kurosawa R, Kawano Y, Yokota S, Sugiyama N, Yuasa H, Fletcher T, Wajdula JS. Etanercept in the treatment of disease-modifying anti-rheumatic drug(DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials. Mod rheumatol .2011;21(6):572-578

9)        Mori M, Murata T, Takei S, Imagawa T, Yokota S. Acquisition of expanded indications for intravenous cyclophosphamide in the management of childhood rheumatic diseases in general. Mod rheumatol. 2011;21(5):449-457

10)     Nishikawa T, Okamoto Y, Tanabe T, Shinkoda Y, Kodama Y, Kakihana Y, Goto M, Kawano Y. Acute respiratory distress syndrome as an initial presentation of hemophagocytic lymphohistiocytosis after induction therapy for acute myeloid leukemia. Pediatr Hematol Oncol. 2011:28(3):244-8

11)     Nishikawa T, Izumo K, Miyahara E, Horiuchi M, Okamoto Y, Kawano Y, Takeuchi T. Benzene induces cytotoxicity without metabolic activation. J Occup Health. 2011;53(2):84-92.

12)     Suematsu R, Ohta A, Matsuura E, Takahashi H, Fujii T, Horiuchi T, Minota S, Ishigatsubo Y, Ota T, Takei S, Soejima S, Inoue H, Koarada S, Tada Y, Nagasawa K. Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan. Mod Rheumatol. 2011 Dec 9 [Epub ahead of print]

13)     Takei S. Systemic JIA as an autoinflammatory disease. Inflammation and Regeneration .2011; 31(1):52-65.

14)     Ueno K, Nomura Y, Arata M, Maruyama S, Tanabe T, Eguchi T, Kawano Y. Development of Kawasaki syndrome in autoimmune neutropenia after treatment with granulocyte colony-stimulating factor. Pediatr Int. 2011;53(3):388-390

15)     Yokota S, Imagawa T, Takei S, Murata T, Tomiita M, Itoh Y, Fujikawa S, Mori M.Guidance on using tocilizumab for juvenile idiopathic arthritis. Mod Rheumatol. 2011;21(6):563-571

16)     Yoshinaga M, Kato Y, Nomura Y, Hazeki D, Yasuda T, Takahashi K, Higaki T, Tanaka Y, Wada A, Horigome H, Takahashi H, Ueno K, Suzuki H, Nagashima M. The QT intervals in infancy and time for infantile ECG screening for long QT syndrome. J Arrhythmia 2011:27;193-201

17)     Kaida M, Morita-Hoshi Y, Soeda A, Wakeda T, Yamaki Y, Kojima Y, Ueno H, Kondo S, Morizane C, Ikeda M, Okusaka T, Takaue Y, Heike Y. Phase 1 trial of Wilms tumor 1 (WT1) peptide vaccine and gemcitabine combination therapy in patients with advanced pancreatic or biliary tract cancer. J Immunother. 2011;34(1):92-9

原著

1)     Hatta M, Endo S, Tokuda K, Kunishima H, Arai K, Yano H, Ishibashi N, Aoyagi T, Yamada M, Inomata S, Kanamori H, Gu Y, Kitagawa M, Hirakata Y, and Kaku M: Post-Tsunami Outbreaks of Influenza in Evacuation Centers in Miyagi Prefecture, Japan. Clin Infect Dis.　2012;54(1):e5-7

2)     Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, Kato T, Hara T, Hamaoka K, Ogawa S, Miura M, Nomura Y, Fuse I, Ichida F, Seki M, Ryuji Fukazawa, Chitose Ogawa, Kenji Furuno, Hirohide Tokunaga, Shinichi Takatsuki, Shinya Hara, Akihiro Morikawa. Efficacyof immunoglobulin plus prednisolone for prevention of coronary artery abnormalitiesin severe Kawasaki disease: a prospective, randomised, open, blinded-endpoint trial. Lancet 2012;379:1613-1620,

3)     Kodama Y, Okamoto Y, Hashiguchi T, Shinkoda Y, Nishikawa T, Tanabe T, Kawano Y. Vascular endothelial growth factor corrected by the platelet count and hematocrit is associated with the clinical course of aplastic anemia in children. Int J Hematol 95:494-499, 2012

4)     Nishikawa T, Miyahara E, Horiuchi M, Izumo K, Okamoto Y, Kawai Y, Kawano Y, Takeuchi T.Benzene Metabolite 1,2,4-Benzenetriol Induces Halogenated DNA and Tyrosines Representing Halogenative Stress in the HL-60 Human Myeloid Cell Line. Environ Health Perspect. 120:62-67, 2012

5)     Nomura Y, Arata M, Masuda K, Koriyama C, Suruki N, Ueno K, Yoshikawa H, Eguchi T, Kawano Y. Kawasaki disease patients with six principal symptoms have a high risk of being a nonresponder. Pedistr Int 54:14-18, 2012

6)     Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, Hamada H, Honda T, Suzuki H, Suenaga T, Takeuchi T, Yoshikawa N, Suzuki Y, Yasukawa K, Ebata R, Higashi K, Saji T, Kemmotsu Y, Takatsuki S, Ouchi K, Kishi F, Yoshikawa T, Nagai T, Hamamoto K, Sato Y, Honda A, Kobayashi H, Sato J, Shibuta S, Miyawaki M, Oishi K, Yamaga H, Aoyagi N, Iwahashi S, Miyashita R, Murata Y, Sasago K, Takahashi A, Kamatani N, Kubo M, Tsunoda T, Hata A, Nakamura Y, Tanaka T, Japan Kawasaki Disease Genome Consortium, Abe J, Kobayashi T, Arakawa H, Ichida F, Nomura Y, Miura M, Ikeda K, Hara T, Fukazawa R, Ogawa S, Hamaoka K; US Kawasaki Disease Genetics Consortium, Newburger JW, Baker AL, Rowley AH, Shulman ST, Melish ME, Mason WH, Takahashi M, Tremoulet AH. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 44:517-521, 2012

7)     Ueno K, Nomura Y, Masamoto I, Masuda K, Morita Y, Eguchi T, Okamoto Y, Kawano Y. Potential role of autoantibody in severe neutropenia of a patient with kawasaki syndrome. Scand J Immunol. 2012;75:120-126.

8)     Yoshikawa H, Nomura Y, Masuda K, Koriyama C, Arata M, Hazeki D, Yanagimoto K, Ueno K, Eguchi T, Kawano Y. Serum procalcitonin value is useful for predicting severity of Kawasaki disease. Pedatr Infect Dis J 31: 523-525, 2012

9)     Nishikawa T, Nakashima K, Fukano R, Okamura J, Inagaki J. Successful treatment with plasma exchange for disseminated cidofovir-resistant adenovirus disease in a pediatric SCT recipient. Bone Marrow Transplant.2012;47(8):1138-9

10)   Maruyama S, Saito Y, Nakagawa E, Saito T, Komaki H, Sugai K, Sasaki M, Kumada S, Saito Y, Tanaka H, Minami N, Goto Y. Importance of CAG repeat length in childhood-onset dentatorubral-pallidoluysian atrophy. J Neurol. 2012;259(11):2329-34

11)   Nishikawa T, Inagaki J, Nagatoshi Y, Fukano R, Nakashima K, Ito N, Sawa D, Kawano Y, Okamura J. The second therapeutic trial for children with hematological malignancies who relapsed after their first allogeneic SCT: Long-term outcomes. Pediatr Transplant. 2012;16(7):722-8

12)     Ayako A, Shintani M, Yagi H, Fujiwara M, Kojima Y, Sato H, Imamura S, Yokozawa M, Onodera N, Horigome H, Kobayashi T, Hatai Y, Nakayama T, Fukushima H, Nishiyama M, Doi S, Ono Y,  Yasukouchi S, Ichida F, Fujimoto K, Ohtsuki S, Teshima H, Kawano T, Nomura Y, Gu H, Ishiwata T, Furutani Y, Inai K, Saji T, Matsuoka R, Nonoyama S, Nakanishi T. Outcomes of Childhood Pulmonary Arterial Hypertension in BMPR2 and ALK1 Mutation Carriers. Am J Cardiol. 2012;110(4):586-593.

13)   Koike T, Harigai M,  Ishiguro N,  Inokuma S, Takei S, Tsutomu Takeuchi T, Yamanaka H, Tanaka Y. Safety and effectiveness of adalimumab in Japanese patients with rheumatoid arthritis: a report of the first 3,000 patients treated during postmarketing surveillance. Mod Rheumatol 2012,22:498-508.

14)   Yokota S, Imagawa T, Murata T, Tomiita M, Itoh Y, Fujikawa S, Takei S, Mori M. Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan. Mod Rheumatol 2012,22:491-497

15)   Imagawa T, Takei S, Umebayashi H, Yamaguchi K, Itoh Y, Kawai T, Iwata N, Murata T, Okafuji I, Miyoshi M, Onoe Y, Kawano Y, Kinjo N, Mori M, Mozaffarian N, Kupper H, Santra S, Patel G, Kawai S, Yokota S. Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan. Clin Rheumatol. 2012 Dec,31(12):1713-21.

16)   Suematsu R, Ohta A, Matsuura E, Takahashi H, Fujii T, Horiuchi T, Minota S, Ishigatsubo Y, Ota T, Takei S, Soejima S, Inoue H, Koarada S, Tada Y, Nagasawa K. Therapeutic response of patients with adult Still’s disease to biologic agents: multicenter results in Japan. Mod Rheumatol 2012,22:712-719.

17)   Mori M, Takei S, Imagawa T, Imanaka H, Nerome Y, Higuchi R, Kawano Y, Yokota S, Sugiyama N, Yuasa H, Eletcher T, Wajdule JS. Safety and efficacy of long-term eatanercept in the treatment of methotrexate-reflactory polyarticular-course juvenile idiopathic arthritis in Japan. Mod Rheumatol 2012,22:720-726.

18)   Yonee C, Toyoshima M, Young SP, Maruyama S, Higuchi I, Narita A, Maegaki Y, Nanba E, Ohno K, Kawano Y. Quantitative computed tomography for enzyme replacement therapy in Pompe disease. Brain Dev 2012 Nov,34(10):834-9.

19)   Fukao T, Maruyama S, Ohura T, Hasegawa Y, Toyoshima M, Haapalainen AM, Kuwada N, Imamura M, Yuasa I, Wierenga RK, Yamaguchi S, Kondo N. Three Japanese Patients with Beta-Ketothiolase Deficiency Who Share a Mutation, c.431A>C (H144P) in ACAT1 : Subtle Abnormality in Urinary Organic Acid Analysis and Blood Acylcarnitine Analysis Using Tandem Mass Spectrometry. JIMD Rep. 2012;3:107-15.

著書

1)     Juvenile Idiopathic Arthritis (JIA): Theory and practicality of tocilizumab treatment. Ed., Takei S, Yokota S, Springer, London, 2012.

原著

1)      Kodama Y, Okamura J, Fukano R, Nakashima K, Ito N, Nishimura M, Abe Y, Suzuki T, Inagaki J. Re-emerging Philadelphia chromosome-positive acute leukaemia more than 20 years after allogeneic  haematopoietic stem cell transplantation. Br J Haematol 2013; 161: 286-289

2)      Shinohara M, Saitoh M, Nishizawa D, Ikeda K, Hirose S, Takanashi JI, Takita J, Kikuchi K, Kubota M, Yamanaka G, Shiihara T, Kumakura A, Kikuchi M, Toyoshima M, Goto T, Yamanouchi H, Mizuguchi M. ADORA2A polymorphism predisposes children to encephalopathy with febrile status epilepticus. Neurology. 2013 Apr 23; 80(17): 1571-1576

3)      Tajiri H, Takeuchi Y, Takano T, Ohura T, AInui A, Yamamoto K, Higashidate Y, Kawashima H, Toyoda S, Ushijima K, Gunasekaran Ramakrishnan, Mats Rosenlund, and Katsiaryna Holl. The burden of rotavirus gastroenteritis and hospital-acquired rotavirus gastroenteritis among children aged less than 6 years in Japan: a retrospective, multicenter epidemiological survey. BMC Pediatrics 2013; 13: 83

4)      Gatayama R, Ueno K, Nakamura H, Yanagi S, Ueda H, Yamagishi H, Yasui S. Nemaline myopathy with dilated cardiomyopathy in childhood. Pediatrics. 2013 Jun; 131(6): e1986-90

5)      Inagaki J, Fukano R, Nishikawa T, Nakashima K, Sawa D, Ito N, Okamura J. Outcomes of Immunological Interventions for Mixed Chimerism Following Allogeneic Stem Cell Transplantation in Children With Juvenile Myelomonocytic Leukemia. Pediatr Blood Cancer 2013; 60: 116-120

6)      Ninomiya Y, Yoshinaga M, Kucho Yu, Tanaka Y. Risk factors for symptoms in long QT syndrome patients in a single pediatric center. Pediatr Int 2013; 55(3): 277-282

7)      Yokota S, Imagawa T, Mori M, Miyamae T, Takei S, Iwata N, Umebayashi H, Murata T, Miyoshi M, Tomiita M, Nishimoto N, Kishimoto T. Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan. Ann Rheum Dis 2013; 472(4): 627-628

8)      Koike T, Harigai M, Ishigur N, Inokuma S, Takei S, Takeuchi T. Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of 7,740 patients. Mod Rheumatol EarlyOnline 2013; 1-9

9)      Koike T, Harigai M, Inokuma S, Ishiguro N, Junnosuke Ryu J, Takeuchi T, Takei S, Tanaka Y, Sano Y, Yaguramaki H, Yamanaka H. Characteristics related to good effectiveness and safety with tocilizumab: Postmarketing surveillance of 7901 rheumatoid arthritis patients in Japan. J Rheumatol (in press) 2013

10)   Chen J, Lee V, Luo CJ, Kwok A, Chiang S, Hongeng S, Tan PL, Tan AM, Sanpakit K, Li CF, Lee AC, Chua HC, Okamoto Y. Allogeneic stem cell transplantation for children with acquired severe aplastic anaemia: a retrospective study by the Viva-Asia Blood and Marrow Transplantation Group. Br J Heamatol 2013; 162: 383-391

11)   Kato M, Takahashi Y, Tomizawa D, Okamoto Y, Inagaki J, Koh K, Ogawa A, Okada K, Cho Y, Takita J, Goto H, Sakamaki H, Yabe H, Kawa K, Suzuki R, Kudo K, Kato K. Comparison of intravenous with oral busulfan in allogeneic hematopoietic stem cell transplantation with myeloablative conditioning regimens for pediatric acute leukemia. Biol Blood Marrow Transplant 2013; 12: 1690-1694

12)   Yonee C, Toyoshima M, Maegaki Y, Kodama Y, Hayami H, Takahashi Y, Kusunoki S, Uchibori A, Chiba A, Kawano Y. Association of acute cerebellar ataxia and human papilloma virus vaccination: a case report. Neuropediatrics. 2013; 44(5): 265-7

13)   Yoshinaga M, Ushinohama H, Sato S, Tauchi N, Horigome H, Takahashi H, Sumitomo N, Kucho Y, Shiraishi H, Nomura Y, Shimizu W and Nagashima M. Electrocardiographic Screening of 1-Month-Old Infants for Identifying Prolonged QT Intervals. Circ Arrhythm Electrophysiol 2013; 6(5): 932-938

14)   Gatayama R, Ueno K, Nakamura H, Yanagi S, Ueda H, Yamagishi H, Yasui S. Nemaline myopathy with dilated cardiomyopathy in childhood. Pediatrics 2013; 131(6): 1986-1990

15)   Inagaki J, Fukano R, Kodama Y, Nishimura M, Okamura J. Gonadal function in patients with severe aplastic anaemia and refractory cytopenia of childhood who undergo bone marrow transplantation after receiving 3-Gy total body irradiation and high-dose cyclophosphamide. Br J Haematol 2013; 163(1): 127-9

16)   Kodama Y, Okamoto Y, Nishi J, Hashiguchi S, Yamaki Y, Kurauchi K, Tanabe T, Shinkoda Y, Nishikawa T, Suda Y, Kawano Y. Ramsay Hunt syndrome in a girl with acute lymphoblastic leukemia during maintenance therapy. J Pediatr Hematol Oncol 2013; 35(5): e224-5

原著

1)      Miyahara E, Nishikawa T, Takeuchi T, Yasuda K, Okamoto Y, Kawano Y, Horiuchi  M. Effect of myeloperoxidase inhibition on gene expression profiles in HL-60 cells exposed to 1, 2, 4,-benzenetriol. Toxicology 2014; 317: 50-57

2)      Yanagimoto K, Nomura Y, Masuda K, Hirabayashi M, Morita Y, Yoshishige M, Ueno K, Eguchi T, Kawano Y. Immunoglobulin G values before treatment are correlated with the responsiveness to initial intravenous immunoglobulin therapy for Kawasaki disease. International Archives of Allergy and Immunology 2014; 164: 83-88

3)      Inagaki J, Fukano R, Kodama Y, Nishimura M, Shimokawa M, Okamura J. Safety and efficacy of low-dose methotrexate for pediatric patients with steroid-refractory acute graft-versus-host disease after hematopoietic stem cell transplantation. Ann Hematol 2014; 93(4): 645-51

4)      Kodama Y, Okamoto Y, Shinkoda Y, Tanabe T, Nishikawa T, Yamaki Y, Kurauchi K, Kawano Y. Bone marrow transplant for a girl with bone marrow failure and cerebral palsy. Pediatr Int  2014; 56(3): 424-6

5)      Fukano R, Nishimura M, Ito N, Nakashima K, Kodama Y, Okamura J, Inagaki J. Efficacy of prophylactic additional cranial irradiation and intrathecal chemotherapy for the prevention of CNS relapse after allogeneic hematopoietic SCT for childhood ALL. Pediatr Transplant 2014; 18(5):518-23

6)      Maegaki Y, Kurozawa Y, Tamasaki A, Togawa M, Tamura A, Hirao M, Nagao A, Kouda T, Okada T, Hayashibara H, Harada Y, Urushibara M, Sugiura C, Sejima H, Tanaka Y, Matsuda-Ohtahara H, Kasai T, Kishi K, Kaji S, Toyoshima M, Kanzaki S, Ohno K; Status Epilepticus Study Group. Early predictors of status epilepticus-associated mortality and morbidity in children. Brain Dev 2014; S0387-7604(14)00191-0

7)      Sakaguchi S, Oda M, Shinkoda Y, Manabe A. Parents’ perception of pediatric cancer centers in Japan. Pediatr Int 2014; 56(2): 196-9

8)      Moritake H, Kamimura S, Nunoi H, Nakayama H, Suminoe A, Inada H, Inagaki J, Yanai F, Okamoto Y, Shinkoda Y, Shimomura M, Itonaga N, Hotta N, Hidaka Y, Ohara O, Yanagimachi M, Nakajima N, Okamura J, Kawano Y. Clinical characteristics and genetic analysis of childhood acute lymphoblastic leukemia with hemophagocytic lymphohistiocytosis: a Japanese retrospective study by the Kyushu-Yamaguchi Children’s Cancer Study Group. Int J Hematol 2014; 100(1): 70-8

9)      Kanamori H, Tokuda K, Ikeda S, Endo S, Ishizawa C, Hirai Y, Takahashi M, Aoyagi T, Hatta M, Gu Y, Yano H, Weber DJ, Kaku M. Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital. Tohoku J Exp Med 2014; 234: 111-116

10)   Endo S, Yano H, Kanamori H, Inomata S, Aoyagi T, Hatta M, Gu Y, Tokuda K, Kitagawa M, and Kaku M. High frequency of Acinetobacter soli among Acinetobacter isolates causing bacteremia at a Japanese tertiary hospital. J Clin Microbiol 2014; 52: 911-915

11)   Kanamori H, Aso N, Tadano S, Saito M, Saito H, Uchiyama B, Ishibashi N, Inomata S, Endo S, Aoyagi T, Hatta M, Yamada M, Gu Y, Tokuda K, Yano H, Kunishima H, Hirakata Y, Saijyo T, Kitagawa M, Kaku M. Tuberculosis Exposure among Evacuees at a Shelter after Earthquake, Japan, 2011. Emerg Infect Dis 2014; 19: 799-801

12)   Tokuda K, Kunishima H, Gu Y, Endo S, Hatta M, Kanamori H, Aoyagi T, Ishibashi N, Inomata S, Yano H, Kitagawa M, Kaku M. A survey conducted immediately after the 2011 Great East Japan Earthquake: evaluation of infectious risks associated with sanitary conditions in evacuation centers. J Infect Chemother 2014; 20: 498-501

13)   Aoyagi T, Kaito C, Sekimizu K, Omae Y, Saito Y, Mao H, Inomata S, Hatta M, Endo S, Kanamori H, Gu Y, Tokuda K, Yano H, Kitagawa M, and Kaku M. Impact of psm-mec in the mobile genetic element on the clinical characteristics and outcome of SCCmec-II methicillin-resistant Staphylococcus aureus bacteremia in Japan. Clin Microbiol Infect 2014; 20: 912-919

14)   Kanamori H, Kakuta R, Yano H, Suzuki T, Gu Y, Oe C, Inomata S, Aoyagi T, Hatta M, Endo S, Tokuda K, Weber DJ, Nakamura Y, Saiki Y, Kaku M. A case of culture-negative endocarditis due to Streptococcus tigurinus. J Infect Chemother 2014 [Epub ahead of print]

15)   Kakuta R, Yano H, Kanamori H, Shimizu T, Gu Y, Hatta M, Aoyagi T, Endo S, Inomata S, Oe C, Tokuda K, Ozawa D, Goto H, Katori Y, Kaku M. Helicobacter cinaedi Infection of Abdominal Aortic Aneurysm, Japan. Emerg Infect Dis 2014; 20: 1942-1945

16)   Kobayashi R, Yabe H, Kikuchi A, Kudo K, Yoshida N, Watanabe K, Muramatsu H, Takahashi Y, Inoue M, Koh K, Inagaki J, Okamoto Y, Sakamaki H, Kawa K, Kato K, Suzuki R, Kojima S. Bloodstream Infection after Stem Cell Transplantation in Children with Idiopathic Aplastic Anemia. Biol Blood Marrow Transplant 2014; 20: 1145-1149

17)   Okamoto Y, Nagatoshi Y, Kosaka Y,  Kikuchi A, Kato S, Kigasawa H, Horikoshi Y, Oda M, Kaneda M, Mori T, Mugishima H, Tsuchida M, Taniguchi S, Kawano Y. Prospective pharmacokinetic study of intravenous busulfan in hematopoietic stem cell transplantation in 25 children. Pediatr Transplant 2014; 18: 294-301

18)   Hyakuna N, Shimomura Y, Watanabe A, Taga T, Kikuta A, Matsushita T, Kogawa K, Kawakami C, Horikoshi Y, Iwai T, Okamoto Y, Tsurusawa M, Asami K, and for The Japanese Childhood Cancer and Leukemia Study Group (JCCLSG). Assessment of Corticosteroid-induced Osteonecrosis in Children Undergoing Chemotherapy for Acute Lymphoblastic Leukemia: A Report From the Japanese Childhood Cancer and Leukemia Study Group. J Pediatr Hematol Oncol 2014; 36: 22-29

19)   Toyoshima M, Okuno T, Maegaki Y, Yonee C, Maruyama S, Nerome Y, Takei S, Kawano Y. Anticardiolipin-IgG Induction is Associated with Primary HumanHerpesvirus-6 Infection.  Med J Kagoshima Univ 2014; 66: 5-13

20)   Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Takei S, Tanaka Y, Sano Y, Yaguramaki H, Yamanaka H. Effectiveness and safety with tocilizumab: Postmarketing surveillance of 7901 rheumatoid arthritis patients in Japan. J Rheumatol 2014; 41(1): 15-23

21)   Ravelli A, Schneider R, Weitzman S, Devlin C, Daimaru K, Yokota S, Takei S, De Benedetti F. A56:macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab. Arthritis Rheumatol 2014; Epub ahead of print

22)   Yokota S, Imagawa T, Mori M, Miyamae T, Takei S, Iwata N, Umebayashi H, Murata T, Miyoshi M, Tomiita M, Nishimoto N, Kishimoto T. Long-term safety and effectiveness of anti-interleukin 6 recetor monoclonal antibody,tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japan. J Rheumatol 2014; 41(4): 759-767

23)   Ikeda K, Kambe N, Takei S, Nakano T, Inoue Y, Tomiita M, Oyake N, Satoh T, Yamatou T, Kubota T, Okafuji I, Kanazawa N, Nishikomori R, Shimojo N, Matsue H, Nakajima H. Ultrasonographic assessment reveals detailed distribution of synovial inflammation in Blau syndrome. Arthritis Res Ther 2014; 16(2) Epub ahead of print.

24)   Yasumura J, Wago M, Okada S, Nishikomori R, Takei S, Kobayashi M.  A 2-year-old Japanese girl with TNF receptor-associated periodic syndrome: A case report of the youngest diagnosed proband in Japan. Mod Rheumatol 2014; Epub ahead of print.

25)   Nerome Y, Kojyo K, Ninomiya Y, Ishikawa T, Ogiso A, Takei S, Kawano Y, Douchi T, Takezaki T, Owaki T. Current human T-cell lymphotropic virus type 1 mother-to-child transmission prevention status in Kagoshima. Pediatr Int 2014; 56(4): 640-643

26)   Davi S, Minoia F, Pistorio A, Horne A, Consolaro A, Rosina S, Bovis F, Cimaz R, Gamir ML, Ilowite NT, Kone-Paut I, Feitosa de Oliveira SK, McCurdy D, Silva CA, Sztajnbok F, Tsitsami E, Unsal E, Weiss JE, Wulffraat N, Abinun M, Aggarwal A, Apaz MT, Astigarraga I, Corona F, Cuttica R, D’Angelo G, Eisenstein EM, Hashad S, Lepore L, Mulaosmanovic V, Nielsen S, Prahalad S, Rigante D, Stanevicha V, Sterba G, Susic G, Takei S, Trauzeddel R, Zletni M, Ruperto N, Martini A, Cron RQ, Ravelli A; Paediatric Rheumatology International Trials Organisation, the Childhood Arthritis and Rheumatology Research Alliance, the Pediatric Rheumatology Collaborative Study Group, and the Histiocyte Society. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheumatol 2014; 66(10): 2871-2880

27)   Kobayashi I, Takezaki S,  Kobayashi N, Iwata N, Mori M, Nagai K, Nakano N,  Miyoshi M,  Kinjo N,  Murata T,  Masunaga K, Umebayashi H, Imagawa T, Agematsu K, Sato S, Kuwana M, Yamada M, Takei S, Yokota S, Koike K, Ariga T.Clinical and laboratory features of fatal rapidly progressive interstitial lung diseases associated with juvenile dermatomyositis. Rheumatology (Oxford) 2014; Epub ahead of print.

28)   Kobayashi I, Mori M, Yamaguchi KI, Ito S, Iwata N, Masunaga K, Shimojo N, Ariga T, Okada K, Takei S. Pediatric Rheumatology Association of Japan recemmendation for vaccination in pediatric rheumatic diseases. Mod Rheumatol 2014; Epub ahead of print.

29)   Miyazono A, Abe J, Ogura M, Sato M, Fujimaru T, Kamei K, Ito S. Successful remission induced by plasma exchange combined with leukocytapheresis against refractory systemic juvenile idiopathic arthritis. Eur J Pediatr 2014; 173(12): 1557-60

著書

1) Yoshinaga M, Miyazaki A, Shinomiya M, Aoki M, Hamajima T, Nagashima M. Impact of sex and lifestyle of adolescents and their parents on obesity. In: Watson RR, editor. Nutrition in the prevention and treatment of abdominal obesity. London: Academic Press 2014; 207-215

原著

1)      Kodama Y, Fukano R, Noguchi M, Okamura J, Inagaki J. Folinic acid after MTX as prophylaxis for GVHD in pediatric bone marrow transplantation. Int J Hematol 2015; 101: 92-8

2)      Nishimura M, Kodama Y, Fukano R, Okamura J, Ogaki K, Sakaguchi Y, Migita M, Inagaki J. Meralgia Paresthetica as a Presentation of Acute Appendicitis in a Girl With Acute Lymphoblastic Leukemia. J Pediatr Hematol Oncol 2015; 37: e182-e183

3)      Manabe A, Kawasaki H, Shimada H, Kato I, Kodama Y, Sato A, Matsumoto K, Kato K, Yabe H, Kudo K, Kato M, Saito T, Saito AM, Tsurusawa M, Horibe K. Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph(+) ALL04. Cancer Med. 2015; 4(5): 682-9

4)      Ueno K, Nomura Y, Morita Y, Eguchi T, Masuda K, Kawano Y. Circulating Platelet-Neutrophil Aggregates Play a Significant Role in Kawasaki Disease. Circulation Journal 2015; 79(6): 1349-1356

5)      Abematsu T, Okamoto Y, Nakagawa S, Kurauchi K, Kodama Y, Nishikawa T, Tanabe T, Shinkoda Y, Mukai M, Kaji T, Kawano Y. Rectosigmoid colon venous malformation successfully treated with propranolol and celecoxib. J Pediatric Surgery Case Reports 2015; 3: 331-333

6)      Tomizawa D，Watanabe T，Hanada R，Horibe K，·Horikoshi Y，Iwamoto S，Kinoshita A， Moritake H，·Nakayama H，Shimada A，Taga T，Takahashi H，Tawa A，Terui K，Hori H，Kawano Y，Kikuta A, Manabe A，Adachi S. Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols. Int J Hematol 2015.July01 DOI  10.1007/s12185-015-1825-x

7)      Inagaki J, Kodama Y, Fukano R, Noguchi M, Okamura J. Mycophenolate mofetil for treatment of steroid-refractory acute graft-versus-host disease after pediatric hematopoietic stem cell transplantation. Pediatr Transplant 2015; 19(6): 652-658

8)      Maegaki Y, Kurozawa Y, Tamasaki A, Togawa M, Tamura A, Hirao M, Nagao A, Kouda T, Okada T, Hayashibara H, Harada Y, Urushibara M, Sugiura C, Sejima H, Tanaka Y, Matsuda-Ohtahara H, Kasai T, Kishi K, Kaji S, Toyoshima M, Kanzaki S, Ohno K; Status Epilepticus Study Group. Early predictors of status epilepticus-associated mortality and morbidity in children. Brain and Development 2015; 37: 478-86

9)      Montassir H, Maegaki Y, Murayama K, Yamazaki T, Kohda M, Ohtake A, Iwasa H, Yatsuka Y, Okazaki Y, Sugiura C, Nagata I, Toyoshima M, Saito Y, Itoh M, Nishino I, Ohno K. Myocerebrohepatopathy spectrum disorder due to POLG mutations: A clinicopathological report. Brain and Development 2015; 37; 719-24.

10)   Nishikawa T, Miyahara E, Kurauchi K, Watanabe E, Ikawa K, Asaba K, Tanabe T, Okamoto Y, Kawano Y. Mechanisms of Fatal Cardiotoxicity following High-Dose Cyclophosphamide Therapy and a Method for Its Prevention. PLoS One 2015; 10(6): e0131394

11)   Wang R, Yoshida K, Toki T, Sawada T, Uechi T, Okuno Y, Sato-Otsubo A, Kudo K, Kamimaki I, Kanezaki R, Shiraishi Y, Chiba K, Tanaka H, Terui K, Sato T, Iribe Y, Ohga S, Kuramitsu M, Hamaguchi I, Ohara A, Hara J, Goi K, Matsubara K, Koike K, Ishiguro A, Okamoto Y, Watanabe K, Kanno H, Kojima S, Miyano S, Kenmochi N, Ogawa S, Ito E. (2015) Loss of function mutations in RPL27 and RPS27 identified by whole-exome sequencing in Diamond-Blackfan anaemia. Br J Haematol 2015; 168: 854-864

12)   Ishida H, Adachi S, Hasegawa D, Okamoto Y, Goto H, Inagaki J, Inoue M, Koh K, Yabe H, Kawa K, Kato K, Atsuta Y, Kudo K. (2015) Comparison of a fludarabine and melphalan combination-based reduced toxicity conditioning with myeloablative conditioning by radiation and/or busulfan in acute myeloid leukemia in Japanese children and adolescents. Pediatr Blood Cancer 2015; 62: 883-889

13)   Kato K, Kato M, Hasegawa D, Kawasaki H, Ishida H, Okamoto Y, Katsuyoshi K, Innoue M, Inagaki J, Kato K, Sakamaki H, Yabe H, Kawa K, Suzuki R, Atsuta Y. (2015) Comparison of transplantation with reduced and myeloablative conditioning for children with acute lymphoblastic leukemia. Blood 2015; 125: 1352-1354

14)   Wakiguchi H, Okamoto Y, Matsunaga M, Kodama Y, Miyazono A, Seki S, Ikeda N, Kawano Y. Multiple Renal and Splenic Lesions in a Child with Cat Scratch Disease. Jap J Infect Dis 2015; DOI:10.7883/yoken.JJID.2015.362

15)   Nakae K, Ueno K, Kawamura J, Yanagimoto K, Eguchi T, Nomura Y, Kakihana Y, Kawano Y. Mechanical circulatory support as a potentially useful strategy in patients with severe cyclophosphamide-induced cardiotoxicity. Med J Kagoshima Univ 2015; 11: 41-50

16)   Fukasawa T, Kubota T, Negoro T, Maruyama S, Honda R, Saito Y, Itoh M, Kakita A, Sugai K, Otsuki T, Kato M, Natsume J, Watanabe K. Two siblings with cortical dysplasia: Clinico-electroencephalographic features. Pediatr Int 2015; 57(3): 472-475

17)   Watanabe E, Nishikawa T, Ikawa K, Yamaguchi H, Abematsu T, Nakagawa S, Kurauchi K, Kodama Y, Tanabe T, Shinkoda Y, Matsumoto K, Okamoto Y, Takeda Y, Kawano Y. Trough level monitoring of intravenous busulfan to estimate the area under the plasma drug concentration-time curve in pediatric hematopoietic stem cell transplant recipients. Int J Hematol 2015; 102(5): 611-616

18)   Yamasaki Y, Takei S, Imanaka H, Nerome Y, Kubota T, Nonaka Y, Akaike H, Takezaki T, Kawano Y. Prediction of long-term remission of oligo/polyarticular juvenile idiopathic arthritis with S100A12 and vascular endothelial growth factor. Mod Rheumatol 2015; Dec 14: 1-6 [Epub ahead of print]

19)   Kubota T, Imanaka H, Takei S, Yamatou T, Nerome Y, Yamasaki Y, Nonaka Y, Akaike H, Takezaki T, Kawano Y. Disease activity score in 28 joints at 3 months after the initiation of biologic agent can be a predictive target for switching to the second biologic agent in patients with polyarticular juvenile idiopathic arthritis. Mod Rheumatol. 2015 Oct 7: 1-4 [Epub ahead of print] 

20)   Inomata S, Yano H, Tokuda K, Kanamori H, Endo S, Ishizawa C, Ogawa M, Ichimura S, Shimojima M, Kakuta R, Ozawa D, Aoyagi T, Gu Y, Hatta M, Oshima K, Nakashima K, Kaku M. Microbiological and molecular epidemiological analyses of community-associated methicillin-resistant Staphylococcus aureus at a tertiary care hospital in Japan. J Infect Chemother. 2015; 21(10): 729-36

21)   Wakamoto H, Sano N, Yano Y, Sakai S,Kikuchi T, Fukuda M, Morimoto T, lshil E. Clinical Usefulness of Serum Krebs von den Lungen-6 for Detecting Chronic Aspiration in Children with Severe Motor and Intellectual Disabilities. THE JOURNAL OF PEDIATRICS 2015; 167(5):1136-42

22)   Imamura T, Tanaka Y, Ninomiya Y, Yoshinaga M. Combination of flecainide and propranolol for congenital junctional ectopic tachycardia. Pediatr Int　2015; 57(4): 716-718

原著

1)      Okamoto Y, Koga Y, Inagaki J, Ozono S, Ueda K, Shimoura M, Itonaga N, Shinkoda Y, Moritake H, Nomura Y, Nakayama H, Hotta N, Hidaka Y, Shimonodan H, Suga N, Tanabe T, Nakashima K, Fukano R, Kawano Y. Effective VCR/DEX pulse maintenance therapy in the KYCCSG ALL-02 protocol for pediatric acute lymphoblastic leukemia. Int J Hematol 2016 ; 103(2): 202-9.

2)      Kodama Y, Okamoto Y, Tanabe T, Nishikawa T, Abematsu T, Nakagawa S, KurauchiK, Shinkoda Y, Ikeda N, Seki S, Wakiguchi H, Miyazono A, Kawano Y. Central venous　catheter-related blood stream infection with pyomyositis due to Stenotrophomonas maltophilia after allogeneic bone marrow transplantation in a patient with aplastic anemia. Pediatr Transplant 2016; 20(2): 329-332

3)      Nakashima K, Kodama Y, Nishikawa T, Nishimura M, Ito N, Fukano R, Nomura Y, Ueba T, Inoue T, Oshima K, Okamura J, Inagaki J. Central nervous system EBV lymphoproliferative disorder in a patient with rhabdomyosarcoma. Pediatr Int 2016; 58(5): 388-390

4)      Ueno K, Ninomiya Y, Shiokawa N, Hazeki D, Eguchi T, Kawano Y. Dexmedetomdine is associated with an increased incidence of bradycardia  in patients with trisomy 21 after surgery for congenital heart disease. Pediatric Cardiology 2016; DOI: 10.1007/s00246-016-1421-8

5)      Miyazono A, Okamoto Y, Nagasako H, Hamasaki Y, Shishido S, Yoshioka T, Kawano Y . Multifocal Epstein-Barr Virus-Negative Posttransplantation Lymphoproliferative Disorder Treated With Reduction of Immunosuppression. Am J Kidney Dis doi: 10.1053/j.ajkd. 2016.03.425

7)　Wakiguchi H, Takei S, Imanaka H, Hiraki T, Higashi M, Yamatou T, Yamasaki Y, Kubota T, Kawano Y. Severe gluteal skin ulcers in an infant with juvenile dermatomyositis. Eur J Dermatol 2016; 26: 192-193. doi: 10.1684/ejd.2015.2701.

8)　Nerome Y, Akaike H, Nonaka Y, Takezaki T, Kubota T, Yamatou T, Yamasaki Y, Imanaka H, Kawano Y, Takei S. The safety and effectiveness of HBV vaccination in patients with juvenile idiopathic arthritis controlled by treatment. Mod Rheumatol 2016; 26(3): 368-371. doi:10.3109/14397595.2015.1085608. Epub 2015 Oct 16.

9) 　Takahashi Y, Ueno K, Ninomiya Y, Eguchi T, Nomura Y, Kawano Y. Potential risk factors for dexmedetomidine withdrawal seizures in infants after surgery for congenital heart disease. Brain&Development 2016; 38(7): 648-53

10) Shinkoda Y, Shirahata A, Fukutake K, Takamatsu J, Shima M, Hanabusa H, Mugishima H, Takedani H, Kawasugi K, Taki M, Matsushita T, Tawa A, Nogami K, Higasa S, Kosaka Y, Fujii T, Sakai M, Migita M, Uchiba M, Kawakami K, Sameshima K, Ohashi Y, Saito H. A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors. Haemophilia 2016; doi: 10.1111/hae.13050. [Epub ahead of print]

11) Wakiguchi H, Okamoto Y, Matsunaga M, Kodama Y, Miyazono A, Seki S, Ikeda N, Kawano Y. Multiple Renal and Splenic Lesions in a child with Cat Scratch Disease. Jpn J Infect Dis 2016; 69: 424-425

12) Shiokawa N, Okamoto Y, Kodama Y, Nishikawa T, Tanabe T, Mukai M, Yoshioka T, Kawano Y.   Conservative treatment of massive hemothorax in a girl with neuroblastoma. Pediatrics International 2016; 58: 1090-1092

13) Saito A, Okamoto Y, Seki Y, Matsunaga M, Nakagawa S, Kodama Y, Nishikawa T, Tanabe T, Kawano Y. DIC complicating APL successfully treated with recombinant thrombomodulin alfa. J pediatr Hematol Oncol 2016; 38(6): e189-e190

14) Sripornsawan P, Okamoto Y, Nishikawa T, Kodama Y, Yamaki Y, Kurauchi K, Tanabe T, Nakagawa S, Shinkoda Y, Imuta N, Kawano Y. Gene expression ratio as a predictive determinant of nelarabine chemosensitivity in T-lymphoblastic leukemia/lymphoma. Pediatr Blood Cancer 2016; 00: 1-4

15) Maruyama S, Okamoto Y, Toyoshima M, Hanaya R, Kawano Y. Immunoglobulin a deficiency following treatment with lamotrigine. Brain&Development 2016; 38(10): 947-949

16) Nakagawa S, Shinkoda Y, Hazeki D, Imamura M, Okamoto Y, Kawakami K, Kawano Y. Central diabetes insipidus as a very late relapse limited to the pituitary stalk in langerhans cell histiocytosis. J Pediatr Endocrinol Metab 2016; 29(7): 873-8

17) Yoshinaga M, Kucho Y, Nishibatake M, Ogata H, Nomura Y. Probability of diagnosing long QT syndrome in children and adolescents according to the criteria of the HRS/EHRA/APHRS expert consensus statement. Eur Heart J. 2016; 37(31): 2490-2497

18) Yoshikawa H, Iwata M, Matsuzaki H, Ono R, Murakami Y, Taba N, Honjo S, Motomura C, Odajima H. Impact of omalizumab on medical cost of childhood asthma in Japan. Pediatr Int. 2016; 58(5): 425-8

19) Nakamura K, Kobayashi M, Yamamoto N, Tokuda K, Miura S, Abe Y, Kashiwazaki J, Aoyagi T, Kaku M, Kanemitsu K. Pertussis outbreak among patients and healthcare workers in a provincial dialysis facility in Japan. J Hosp Infect  2016; [Epub ahead of print]

20) Tokuda K, Yahata Y, Sunagawa T. Prevention of secondary household transmission during Shiga toxin-producing Escherichia coli outbreaks. Epidemiol Infect 2016; 144(14): 2931-9

21) Imuta N, Ooka T, Seto K, Kawahara R, Koriyama T, Kojyo T, Iguchi A, Tokuda K, Kawamura H, Yoshiie K, Ogura Y, Hayashi T, Nishi J. Phylogenetic Analysis of Enteroaggregative Escherichia coli (EAEC) Isolates from Japan Reveals Emergence of CTX-M-14-Producing EAEC O25:H4 Clones Related to Sequence Type 131. J Clin Microbiol 2016; 54(8): 2128-34

22)Kawamura H, Tokuda K, Imuta N, Kubota T, Koriyama T, Miyanohara H, Hashiguchi T,  Kawano Y, Nishi J. Epidemiological Analysis of Nosocomial MRSA Outbreaks Using Phage Open-Reading Frame Typing in a Tertiary-care Hospital. Jpn J Infect Dis 2016; [Epub ahead of print]

23)Kawamura H, Matsumoto K, Shigemi A, Orita M, Nakagawa A, Nozima S, Tominaga H, Setoguchi T, Komiya S, Tokuda K, Nishi J. A bundle that includes active surveillance, contact precaution for carriers, and cefazolin-based antimicrobial prophylaxis prevents methicillin-resistant Staphylococcus aureus infections in clean orthopedic surgery. Am J Infect Control 2016; 44(2): 210-4

24) Imamura T, Kiyokawa N, Kato M, Imai C, Okamoto Y, Yano M, Ohki K, Yamashita Y, Kodama Y, Saito A, Mori M, Ishimaru S, Deguchi T, Hashii Y, Shimomura Y, Hori T, Kato K, Goto H, Ogawa C, Koh K, Taki T, Manabe A, Sato A, Kikuta A, Adachi S, Horibe K, Ohara A, Watanabe A, Kawano Y, Ishii E, Shimada H. Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan. Blood Cancer J  2016;  6: e419

25) Koh K, Ogawa C, Okamoto Y, Kudo K, Inagaki J, Morimoto T, Mizukami H, Ecstein-Fraisse E, Kikuta A. Phase 1 study of clofarabine in pediatric patients with relapsed/refractory acute lymphoblastic leukemia in Japan. Int J Hematol 2016; 104: 245-255

26) Hirabayashi M, Yoshinaga M, Nomura Y, Ushinohama H, Sato S, Tauchi N, Horigome H, Takahashi H, Sumitomo N, Shiraishi H, Nagashima M. Environmental risk factors for sudden infant death syndrome in Japan. Eur J Pediatr  2016; 175(12): 1921-1926

原著

1)   Ikeda N, Maruyama S, Nakano K, Imakiire R, Ninomiya Y, Seki S, Yanagimoto K, Kakihana Y, Hara K, Tajima G, Okamoto Y, Kawano Y. A surviving 24-month-old patient with neonatal-onset carnitine palmitoyltransferase II deficiency．Mol Genet Metab Rep. 2017 May 9;11:69-71.

2)      Kodama Y, Manabe A, Kawasaki H, Kato I, Kato K, Sato A, Matsumoto K, Kato M,　Hiramatsu H, Sano H, Kaneko T, Oda M, Saito AM, Adachi S, Horibe K, Mizutani S, Ishii E, Shimada H. Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia. Pediatr Blood Cancer. 2017; 64: e26423.

3)      Kodama Y, Okamoto Y, Kubota T, Hiroyama Y, Fukami H, Matsushita K, Kawano Y. Effectiveness of vitamin K2 on osteoporosis in adults with cerebral palsy. Brain  Dev. 2017  pii: S0387-7604(17)30152-3. doi:10.1016/j.braindev.2017.05.012. [Epub ahead of print] PubMed PMID: 28624135.

4)      Kurauchi K, Nishikawa T, Miyahara E, Okamoto Y, Kawano Y. Role of metabolites of cyclophosphamide in cardiotoxicity. BMC Res Notes. 2017; 10(1):406.

5)   Mimori T, Harigai M, Atsumi T, Fujii T, Kuwana M, Matsuno H, Momohara S, Takei S, Tamura N, Takasaki Y, Ikeuchi S, Kushimoto S, Koike T.  Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan.  Mod Rheumatol. 2017 Sep;27(5):755-765.

6)   Miyamae T, Takei S, Itoh Y, Yamanaka H. Survey of attitudes of non-pediatric rheumatologists among councilors of the Japan College of Rheumatology regarding transitional care.  Mod Rheumatol. 2017 Nov;27(6):1047-1050.

7)   Nagakura T, Wakiguchi H, Kubota T, Yamatou T, Yamasaki Y, Nonaka Y, Nerome Y, Akaike H, Takezaki T, Imanaka H, Kawano Y, Takei S. Tumor Necrosis Factor Inhibitors Provide Longterm Clinical Benefits in Pediatric and Young Adult Patients with Blau Syndrome. J Rheumatol 2017;44;536-538

8)   Nakagawa S, Okamoto Y, Kodama Y, Nishikawa T, Tanabe T, Kawano Y.　Thiamylal Plus Pentazocine Shows Similar Efficacy as Ketamine Plus Midazolam for Painful Procedures in Children With Leukemia. J Pediatr Hematol Oncol. 2017 Dec 12.

9)   Okamoto Y, Kodama Y, Nishikawa T, Rindiarti A, Tanabe T, Nakagawa S, Yoshioka T, Takumi K, Kaji T, Kawano Y. Persistent positive metaiodobenzylguanidine scans after autologous peripheral blood stem cell transplantation may indicate maturation of stage 4 neuroblastoma. Pediatr Hematol Oncol. 2017 Apr;34(3):157-164.

10)      Okano T, Nishikawa T, Watanabe E, Watanabe T, Takashima T, Yeh TW, Yamashita M, Tanaka-Kubota M, Miyamoto S, Mitsuiki N, Takagi M, Kawano Y, Mochizuki Y, Imai K, Kanegane H, Morio T. Maternal T and B cell engraftment in two cases of X-linked severe combined immunodeficiency with IgG1 gammopathy. Clin Immunol. 2017 pii: S1521-6616(17)30058-X. doi: 10.1016/j.clim.2017.08.003.

11)   Pornpun P, Okamoto Y, Nishikawa T, Kodama Y, Yamaki Y, Kurauchi K, Tanabe T, Nakagawa S, Shinkoda Y, Imuta N, Kawano Y. Gene expression ratio as a predictive determinant of nelarabine chemosensitivity in T-lymphoblastic leukemia/lymphoma. Pediatr Blood Cancer. Pediatr Blood Cancer. 2017 Feb;64(2):250-253, corresponding author. IF: 2.634

12)      Seki S, Ueno K, Matsunaga M, Hazeki D, Kawano Y. Atrioventricular reciprocating tachycardia in a girl with atrial fibrillation. Pediatrics International 2017 doi: 10.1111/ped.13346. [Epub ahead of print]

13)   Tajima G, Hara K, Tsumura M, Kagawa R, Okada S, Sakura N, Maruyama S, Noguchi A, Awaya T, Ishige M, Ishige N, Musha I, Ajihara S, Ohtake A, Naito E, Hamada Y, Kono T, Asada T, Sasai H, Fukao T, Fujiki R, Ohara O, Bo R, Yamada K, Kobayashi H, Hasegawa Y, Yamaguchi S, Takayanagi M, Hata I, Shigematsu Y, Kobayashi M. Newborn screening for carnitine palmitoyltransferase II deficiency using (C16+C18:1)/C2: Evaluation of additional indices for adequate sensitivity and lower false-positivity. Mol Genet Metab. 2017 Nov;122(3):67-75.

14)   Tanaka Yuji．Thrombotic or Bleeding Complications in Patients Undergoing the Fontan Procedure and Receiving Prophylactic Anticoagulation and/or Antiplatelet Therapy. Journal of Pediatric Cardiology and Cardiac Surgery 2017; 1: 70-78 (doi:10.24509/jpccs.170112)

15)      Ueno K, Ninomiya Y, Hazeki D, Masuda K, Nomura Y, Kawano Y. Disruption of Endothelial Cell Homeostasis Plays a Key Role in the Early Pathogenesis of Coronary Artery Abnormalities in Kawasaki Disease. Sci Rep. 2017; doi: 10.1038/srep43719.

16)   Wakiguchi H, Takei S, Kawano Y. Axillary skin ulcers in infants with juvenile dermatomyositis.  Pediatr Neonatol. 2017 Jun;58(3):287-288.

17)      Wakiguchi H, Takei S, Kubota T, Miyazono A, Kawano Y. Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels. Clin Rheumatol  2017; 36(2): 433-437

18) Yamamoto T, Shimojima K, Matsufuji M, Mashima R, Sakai E, Okuyama T.  Aspartylglucosaminuria caused by a novel homozygous mutation in the AGA gene was identified by an exome-first approach in a patient from Japan Brain and Development 2017 May; 39(5): 422-425

19)      Yanagimoto K, Okamoto Y, Kodama Y, Nishikawa T, Tanabe T, Kawano Y. Decrease of cardiac base rotation in 2D speckle tracking indicates drug-induced cardiomyopathy after chemotherapy in children with cancer. Journal of Pediatric Hematology/Oncology  2017; 39(1): 10-14

著書

1) Mayumi Matsufuji, Nozomi Sano, Hisashi Tsuru, Sachiko Takashima．Neuromaging and neuropathological characteristics of cerebellar injury in extremely low birth weight infants．Brain&Development 39 (2017) 735-742.